Downing FOUR VCT plc Net Asset Value(s)
20 Septiembre 2021 - 12:26PM
UK Regulatory
TIDMD467
Downing FOUR VCT plc (the "Company")
LEI: 21380035MV1VRYEXPR95
20 September 2021
Net Asset Values
The Directors of the Company note that the quoted share price of
investee Company, Arecor Therapeutics plc, has today (at the close
of the market) increased by approximately 30% on the previous
close. This increase in the quoted bid price, along with the
movements in the bid prices of the other quoted investments held by
the Generalist (Ventures) and Healthcare Share classes, has
resulted in increases in value equivalent to 1.2p per Generalist
(Ventures) Share and 6.3p per Healthcare Share, in NAV terms.
The valuation of the unquoted investments remain at their 31
July 2021 levels, but will be reviewed again prior to the
publication of the Half-Yearly Report for the six months to 30
September 2021.
Adjusting the unaudited 31 July 2021 NAVs for the movements
noted above, the unaudited NAVs of the Generalist (Ventures) and
Healthcare Share classes have increased to 67.7p per Generalist
(Ventures) Share and 87.8p per Healthcare Share. These unaudited
NAVs are stated prior to the payment of the forthcoming dividends,
of 2.75p per Generalist (Ventures) Share and 2.75p per Healthcare
Share, which are due to be paid on Friday 24 September 2021.
(END) Dow Jones Newswires
September 20, 2021 13:26 ET (17:26 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Thames Ventures Vct 2 (LSE:D467)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Thames Ventures Vct 2 (LSE:D467)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024